Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
Clinical trial NCT04497038 · TERMINATED
Trial details
- NCT number
- NCT04497038
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2023-05-02
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.